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Glomerular hemodynamics in cyclosporine nephrotoxicity
following uninephrectomy
JONATHAN A. WINSTON, ROBERT FEINGOLD, and ROBERT SAFIRSTEIN
Division of Renal Diseases, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
Glomerular hemoclynamics in cyclosporine nephrotoxicity following
uninephrectomy. Experiments were performed to determine the cause
of the reduced glomerular filtration rate (GFR) in cyclosporine nephro-
toxicity during compensatory renal growth. Sprague-Dawley rats were
uninephrectomized and given daily injections of cyclosporine (30 mgI
kg, i.m.) or vehicle (olive oil), and studied 7 or 14 days later. In
cyclosporine treated rats GFR was lower seven days (1.34 0.10 vs.
1.68 0.07 mI/mm) and 14 days (1.19 0.08 vs. 1.58 0.04, P <0.025)
following uninephrectomy. Arterial blood pressure, cardiac output and
renal blood flow (RBF) were not different in cyclosporine and control
rats. Kidney mass increased to the same extent in cyclosporine and
control rats. Micropuncture of the glomerular microcirculation in
similarly prepared Munich-Wistar rats demonstrated low whole kidney
GFR (1.10 0.07 vs. 1.55 0.13 mllmin, P <0.01), and single nephron
GFR (31.07 2.27 vs. 42.36 2.47 nI/mm, P < 0.005) in cyclosporine
treated rats as compared to controls. Single nephron plasma flow,
afferent and efferent arteriolar resistance, the transglomerular hydro-
static pressure gradient, and arterial blood pressure were the same in
both groups. The glomerular capillary ultrafiltration coefficient (Kr) was
lower in cyclosporine treated rats compared to controls [0.039 0.002
vs. 0.075 0.013 nl/(sec . mm Hg), P < 0.0251. We conclude that in this
model of cyclosporine nephrotoxicity the low GFR is caused solely by
a reduction in Kf, and that cyclosporine can reduce GFR without
causing renal vasoconstriction.
Immunosuppression with cyclosporine immediately follow-
ing renal transplantation is frequently complicated by acute
renal failure [1—5]. More chronic administration improves graft
survival but is associated with higher levels of serum creatinine
than are found in a cohort of patients treated with azathioprine
[6]. The effects of allograft rejection and ischemia on kidney
function, however, have obscured a clear understanding of the
pathogenesis of this syndrome as it occurs in man. Experimen-
tal evidence suggests that the fall in glomerular filtration rate
(GFR) in cyclosporine nephrotoxicity is due to renal vasocon-
striction [7—12], but the fall in GFR can be disproportionate to
changes in renal blood flow [(RBF), 8] and selective hypofiltra-
lion in the absence of lowered renal perfusion has been reported
[13]. The hemodynamic determinants of the reduced GFR in
chronic cyclosporine nephrotoxicity need further clarification.
For these reasons we have performed experiments to deter-
mine the hemodynamic determinants of the reduced glomerular
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filtration in an animal model of cyclosporine nephrotoxicity that
simulates events occurring after renal transplantation in man.
Kidneys transplanted into anephric recipients undergo compen-
satory changes in growth and function equal in magnitude to
that which occurs following donor uninephrectomy [14—16]. We
therefore studied the effects of cyclosporine when it is admin-
istered chronically to rats following uninephrectomy. The ef-
fects of cyclosporine on renal function during compensatory
renal growth could then be studied in the absence of ischemia
and rejection. Our studies show that cyclosporine does not
interfere with the expected increase in renal mass following
uninephrectomy. Cyclosporine reduces GFR when given after
uninephrectomy, but the reduced GFR is not caused by renal
vasoconstriction or changes in renal vascular resistance. The
fall in GFR is due to a reduction in the glomerular capillary
ultrafiltration coefficient (Kf).
Methods
Balance and clearance experiments were performed in a total
of 74 Sprague-Dawley rats (275 to 325 g) and micropuncture in
sixteen Munich-Wistar rats (200 to 275 g).
Animal preparation
Daily administration of cyclosporine to rats reduces food
intake, and animals so treated lose weight [7, 10, 17, 18]. For
this reason our studies were performed under conditions of
paired feeding so that differences in food intake would not be
responsible for any observed differences in renal hemodynam-
ics or renal growth. All animals were placed in metal metabolic
cages fitted with fine-mesh screens. Each animal was offered 15
grams of a standard rat chow (Rat Chow 5012, Ralston Purina
Co., St. Louis, Missouri, USA, containing 22.8% protein, 4.5%
fat, 4.6% fiber and water) and 50 ml of tap water daily. After a
period of four to six days, when rats ate their allotted portions
of food, they underwent a right uninephrectomy. Using sterile
conditions and ether anesthesia the kidney was approached via
a flank incision, carefully avoiding the adrenal vessels. Follow-
ing uninephrectomy and for 7 to 14 days thereafter animals
received daily intramuscular injections of cyclosporine (San-
dimmuneR, Sandoz, Inc., East Hanover, New Jersey) 30 mg/kg
body weight, or its vehicle, olive oil. The daily consumption of
food and water was measured for each cyclosporine-treated
animal and on the following day these quantities were pair-fed
to controls. Urine was collected under oil in plastic cylinders to
which thymol was added. Each day the rats were weighed and
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the 24-hour urine volume measured. A portion of the urine was
frozen and stored at —20°C for later analysis of osmolality,
sodium, and potassium concentration. In Sprague-Dawley rats
glomerular filtration rate, renal blood flow and cardiac output
were measured 7 or 14 days after uninephrectomy. In Munich-
Wistar rats micropuncture was performed 7 to 10 days after
uninephrectomy. Drug administration was witheld on the morn-
ing of study to minimize any acute effects of cyclosporine on
renal function. Whole blood cyclosporine levels were measured
in a separate group of similarly prepared cyclosporine injected
Sprague-Dawley (N 5) and Munich-Wistar rats (N = 4) seven
days after uninephrectomy and, as above, 24 hours following
the last dose.
Clearance studies
The preparation of rats for clearance, blood flow and micro-
puncture experiments has been described previously [19]. Gb-
merular filtration rate was measured in 21 control and 24
cyclosporine treated Sprague-Dawley rats. Animals were anes-
thetized with mactin (Andrew Lockwood Associates, East
Lansing, Michigan, USA) 100 mg/kg i.p. and placed on a heated
surgical table. Body temperature, monitored by a rectal tem-
perature probe (Yellow Springs Instrument Co., Yellow
Springs, Ohio, USA), was maintained at 37 to 38°C. Polyethyl-
ene catheters were placed in the carotid artery, jugular vein and
dome of the bladder. The catheter placed in the carotid artery
was used for blood sampling and for measuring arterial pressure
(AP) with a strain-gauge transducer (Ailtech, City of Industry,
California, USA) connected to a recorder (Gould Inc., Cleve-
land, Ohio, USA). After cannulation of the jugular vein an
infusion of isotonic NaC1 (125 mM)/NaHCO3 (25 mM) was
begun at 1.0 mlJlOO g body weight/hr using a constant infusion
pump (Sage, Orion Research, Cambridge, Massachusetts,
USA). The infusion solution contained enough methoxy-
3H]inulin (ICN Pharmaceutical Co., Irvine, California, USA) to
deliver 10 to 15 jiCi per hour. Approximately 100 minutes after
the infusions were started, 150 pA of blood was taken and the
first of three 20 to 30 minute urine collections was begun. Blood
samples were taken at 30 minute intervals throughout the
experiment and spun immediately in a microcentrifuge to sep-
arate plasma from blood cells. The urine specimens were
weighed and portions of plasma and urine pipetted into scintil-
lation vials to determine the 3H activity. At the conclusion of
the experiment the left kidney was removed and weighed.
Kidney growth was expressed as the difference in wet weight
between the remnant kidney on the day of experiments and the
contralateral kidney weighed at the time of uninephrectomy.
Renal blood flow and cardiac output were measured with 15
3 jim (OD) 85Sr-labeled microspheres (sp act 10 mCi/g; 3M
Company, St. Paul, Minnesota, USA) in 13 control and 12
cyclosporine treated rats 20]. In these studies additional cath-
eters were placed in the femoral arteries to monitor blood
pressure during sphere injection and to withdraw blood. At the
end of the last clearance period, the carotid artery catheter was
advanced into the left ventricle and the position of the catheter
confirmed by the characteristics of the pressure tracing in vivo
and later at autopsy. Microspheres were then injected as a bolus
through the carotid catheter in sufficient numbers to deliver a
minimum of 16,000 counts/mm to the kidney. Beginning imme-
diately after the administration of the microspheres, and eon-
tinuing for the next 60 seconds blood was withdrawn from the
femoral artery at a constant rate using a withdrawal pump
(model 351, Sage Instruments, Cambridge, Massachusetts,
USA). After this time the abdominal cavity was opened, and the
kidney removed, decapsulated, and placed in a preweighed
glass vial containing concentrated HCI. After overnight diges-
tion, the mixed digests and samples of femoral arterial blood
were counted for calculation of renal blood flow.
In three control and three treated rats renal blood flow was
measured concurrently with an electromagnetic flow probe
(Model ElOI.S, lumen size 1.5 m, Carolina Medical Electron-
ics, Inc., King, North Carolina, USA), and in two control and
one cyclosporine animal RBF was measured by flow probe
only. Because the left kidney was partially exposed for place-
ment of the flow probe the surgical preparation used was similar
to that used for micropuncture and the infusion protocol was
modified to correct for fluid lost during surgery (vide infra).
Mean values for RBF and GFR within each group did not differ
whether rats were studied using microspheres or flow probe
methodology, and values for GFR and RBF have been com-
bined within each group.
Micropuncture
Eight control and eight cyclosporine treated Munich-Wistar
rats were studied with micropuncture techniques. The left
kidney was exposed through a flank incision, carefully freed
from the surrounding perirenal fat, and supported in a plastic
cup. Its surface was bathed with mineral oil warmed to 38°C and
illuminated with a fiber-optic illuminator fitted with an infrared
filter to minimize heat. The ureter was cannulated with a PE-lO
tubing and urine was collected under oil into preweighed test
tubes. To restore fluid lost during surgery [21], isoncotic donor
rat plasma was infused through a second jugular catheter at a
rate of 1.25% body weight over 30 minutes followed by a
constant infusion of 10 jil/min and adjusted to replace urine
output and to keep the hematocrit stable. The inulin concentra-
tion of the NaC1/NaHCO3 infusion was adjusted to deliver 150
jzCi of [methoxy-3H1 inulin per hour.
Superficial proximal tubules were punctured at random using
8 to 10 jim OD micropipettes. An oil block three to four tubule
diameters in length was injected prior to tubule fluid collections
and held in place when necessary by applying gentle suction
through the collection pipet. Exactly timed (2 to 4 mm) collec-
tions of tubule fluid were obtained in at least four nephrons per
animal. Blood was collected from superficial star vessels using
glass pipettes 12 to 14 jim OD coated inside and out with a
siliconizing solution (2% Dow Corning 1107). The hydrostatic
pressure in superficial glomeruli (Gd, proximal tubules (UT)
and star vessels (P,) were measured using glass micropipettes
(1 to 2 jim OD) filled with 2 M NaC1 and attached to a
servo-nulling pressure system (Model 5, Instrumentation for
Physiology and Medicine, Inc., San Diego, California, USA).
The criteria for accurate measurements of P0 in this fashion
have been described by others 22, 23] and include a tracing
which is synchronous to the simultaneously-recorded arterial
pressure wave and unaccompanied by glomerular bleeding. In
one cyclosporine treated animal and one control, surface gb-
meruli were not present and P0 was measured by means of
stop-flow pressure (nsF) [19].
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Calculations
The concentration of Na and K in plasma and urine was
measured by flame photometry (Instrumentation Laboratory,
Lexington, Massachusetts, USA). Osmolality was measured by
vapor pressure osmometry (Wescor, Ogden, Utah). 3H activity
in urine, plasma, and tubule fluid was determined in a liquid
scintillation spectrometer (Packard Tri-Carb model 2425, Dow-
ners Grove, Illinois, USA). 855r activity in blood and kidney
digests was determined in an Auto-Gamma scintillation spec-
trometer (Packard, Downers Grove, Illinois, USA). Cyclo-
sporine levels in whole blood were measured by radioimmuno-
assay (Sandimmune' Radioimmunoassay Kit, Sandoz, East
Hanover, New Jersey, USA).
The protein concentration in afferent arteriolar (CA) and
efferent arteriolar (CE) plasma was measured from samples of
systemic and star vessel blood, respectively, using the OPT
method described by Viets et al [24]. Three-five nanoliter
aliquots of plasma samples were transferred to microcuvettes
made from 100 tl capillary tube previously filled with 5 d of 0.4
M borate buffer [(ph 9.3), mercaptoethanol (0.3%), and Brij
solution (0.1%)]. Following transfer, 5 p1 of the OPT reagent
(40% in 0.4 M borate buffer) was added and the capillary tubes
sealed, mixed by centrifugation, and their fluorescence read on
a fluorescence spectrophotometer (Model LS 5, Perkin-Elmer).
Standard curves were run for each experiment using samples of
plasma obtained from Munich-Wistar rats whose protein con-
centration was routinely standardized using the method of
Lowry et al [25].
Whole kidney GFR was determined by the ratio of the inulin
activities in urine and plasma multiplied by the urine flow rates
in ml/min. Renal blood flow was calculated using the formula:
total renal blood flow (RBF) =
Kidney activity (counts/mm) x blood withdrawal rate (mI/mm)
arterial blood activity (counts/mm)
and cardiac output (CO) =
counts/mm injected x blood withdrawal rate (mI/mm)
arterial blood activity (counts/mm)
SNGFR was calculated by the inulin activity in timed tubule
fluid collections (cpm/min) divided by the plasma inulin activity
(cpm/nl). The oncotic pressure of afferent (HA) and efferent
arteriolar (HE) blood was calculated from the formula of Landis
and Pappenheimer [26] as modified by Deen, Robertson and
Brenner [27] where H = 1.629 C + 0.294 C2, and C (g/l00 ml) is
the concentration of protein in rat plasma.
Single nephron filtration fraction was calculated by the for-
mula:
SNFF = 1 — CA/CE
Single nephron plasma flow (QA) was calculated by:
QA = SNGFR/SNFF;
Glomerular blood flow (GBF) and efferent arteriolar blood
flow (EABF) were calculated by:
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Fig. 1. Mean values I SEM for the daily
change in body weight, expressed as the %
change in weight from the day of uninephrec-
tomy (Day I), daily urine volume and daily
sodium and potassium excretion in control(•) and cyclosporine-treated (0) Sprague-
Dawley rats.
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FIg. 2. Mean values 1 SEM for cumulative sodium and potassium
excretion in control (E) and cyclosporine-treated (0) Sprague-Dawley
rats.
GBF = QA/l — Hct;
EABF = GBF — SNGFR.
The transglomerular hydrostatic pressure gradient (AP) is the
difference between Gc and In the two rats without surface
glomeruli GC sF + 11A'
Resistances in afferent (RA) and efferent arterioles (RE) were
calculated by the equations:
RA = [AP — P/GBF] x [7.962 x 1010 dyn sec
RE [Gc — Psv/EABFJ x [7.962 x lO'° dyn• sec . cm5J
The glomerular capillary ultrafiltration coefficient (Kr) was
calculated using a computerized iterative method similar to that
developed by others [27, 28].
Statistical analysis
Results are expressed as mean SE. The statistical signifi-
cance of the results was assessed by Student's t-test with paired
and unpaired data as indicated. Significance is indicated by a P
value of 0.05 or less.
Results
Balance studies were carried out for 14 days in 26 pairs of
Sprague-Dawley rats. Mean values for changes in body weight
(expressed as % of body weight on day of uninephrectomy),
daily urine volume and electrolyte excretion are shown in
Figure 1. At the time of uninephrectomy mean values for body
weight were the same in rats who subsequently received
cyclosporine compared to their respective controls, After seven
days of treatment with cyclosporine rats lost an average of 13
Fig. 3. Mean values 1 SEM for GFR and RBF in Sprague-Dawley
rats 7 days (A) and 14 days (B) a,fter cyclosporine (0) or vehicle (12).
4 g of body weight, a value not different than the weight loss in
controls (13 6 g body weight). By day 11, though, body
weight was significantly less in cyclosporine treated rats com-
pared to controls (P C 0.01). The lower body weight was not
due to differences in food intake, as cyclosporine and control
animals were pair-fed, nor was it due to an increase in urine
volume or electrolyte excretion in cyclosporine treated rats,
Urine volume was reduced in cyclosporine treated animals on
the first day after uninephrectomy, and the daily sodium excre-
tion in cyclosporine treated rats tended to be lower than in
controls throughout the study. Daily potassium excretion in
cyclosporine treated animals also tended to be lower than
pair-fed controls and reached statistical significance on days 5,
9, 11, and 12.
Cumulative sodium and potassium excretion, shown in Fig-
ure 2, was consistently and significantly lower in cyclosporine
treated animals compared to controls beginning on the fifth and
seventh day, respectively. No excessive gastrointestinal losses
were noted in cyclosporine treated rats. After seven days of
observation mean values for serum Na in cyclosporine treated
rats (145 1 mEq/liter) were not different than controls (145
2), while both serum K concentration (4.7 0.1 vs. 4.1 + 0.1,
Eq
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Table 1. Gb merular hemodynamics in control and cycbosporine treated Munich-Wistar rats
AP POC 'T Psv CA CE
gidI
t1A 11E
mm Hg
SNGFR
nllmin
QA RA RE
xIO'°dyn .
sec cm5 Kfnl/(sec. mm Hg)mm Hg
Control
1
2
3
4
5
6
7
8
X
98
109
104
105
120
113
85
99
104
4
54 16
56 12
44 15
47 13
53 14
52 15
45 13
52 14
50 14
2 1
18
13
16
16
16
17
14
17
16
1
5.5
5.8
5.9
5.5
6.1
5.9
5.1
6.6
5.8
0.2
7.7
7.3
7.3
8.7
8.0
7.5
7.7
8.4
7.8
0.2
17.85 29.97
19.34 27.56
19.85 27.56
17.85 36.43
20.88 31.85
19.85 28.78
15.95 29.97
23.56 34.43
19.39 30.82
0.81 1.14
43.66
40.89
40.35
33.83
51.03
44.04
32.97
52.08
42.36
2.47
152.8
199.0
210.4
92.0
214.9
206.4
97.6
243.0
177.0
20.0
1.26 1.22
1.17 1.07
1.41 0.75
2.96 2.02
1.24 0.78
1.27 0.82
1.73 1.63
0.86 0.73
1.49 1.13
0.23 0.17
0.052
0.033
0.148
0070b
0.068
0.058
0.068
0.104
0.075
0.013
Cyclosporine
1
2
3
4
5
6
7
8
X
96
103
88
103
104
93
97
107
99
2
54 18
48 14
49 14
41 13
56 18
50 13
45 13
55 15
50 15
2 1
20
16
15
14
22
15
15
18
17
1
6.1
5.4
5.0
5.3
5.5
5.5
5.0
5.5
5.4
0.1
7.1
7,1
6.5
6.5
7.0
7.3
7.0
6.8
6.9
0.1
20.88 26.39
17.37 26.39
15.50 23.01
16.89 23.01
17.85 25.81
17.85 27.56
15.50 25.81
17.85 24.67
17.46 25.33
0.66 0.58
25.93
27.95
34.08
22.40
27.50
36.12
32.12
42.45
31.07
2.27
184.1
116.7
147.7
121.3
128.3
146.5
112.4
222.5
147.4
13.5
1.05 0.93
2.21 1.50
1.22 1.23
2.32 1.13
1.55 1.23
1.31 1.24
1.88 1.27
1.03 0.82
1.57 1.17
0.18 0.08
0.035
0.039
0.036
0.047
0.028
0.042
0.047
0.038
0.039
0.002
P NS NS NS NS NS 0.001 NS 0.001 0.005 NS NS NS 0.025
a p measured by means of stop-flow pressureb Minimum value for K
P < 0.005) and BUN (29.5 1.9 vs. 18.7 0.8 mg/dl, P <
0.001) were higher in cyclosporine treated rats. A similar trend
was noted after 14 days of treatment. Mean values for whole
blood cyclosporine levels were 4306 181 tg!ml (N = 5).
The results of clearance studies are summarized in Figure 3.
Compared to controls, GFR was lower in cyclosporine treated
rats on day 7(1.34 .10 vs. 1.68 .07 ml/min, P < 0.025) and
day 14(1.19 .08 vs. 1.58 .04, P < 0.025). The reduction in
GFR on day 7 was not due to differences in systemic hemody-
namics as systemic blood pressure (98 3 control vs. 105 2
mm Hg, cyclosporine) and cardiac output (269 9 control vs.
296 13 ml/min/kg body weight, cyclosporine) was the same in
both groups. Similarly, blood pressure and cardiac output were
not different at 14 days. In addition, the low GFR in cyclo-
sporine treated rats was not due to differences in renal blood
flow as values for renal blood flow were equal in cyclosporine
treated rats and controls on day 7(11.6 0.7 vs. 10.8 0.4 ml!
mm) and day 14 (10.4 0.7 vs. 9.9 0.2, respectively). After
seven days of treatment kidney weight increased 137.4 18.2
mg in cyclosporine rats, a value equal in magnitude to the
increase in kidney weight observed in controls (196.6 26.3
mg).
To explore the determinants of the reduced GFR in this
model of cyclosporine nephrotoxicity further, we prepared
Munich-Wistar rats in a similar fashion and measured glomer-
ular hemodynamics in cyclosporine and control rats 7 to 10 days
after uninephrectomy (Table 1). Similar to the situation ob-
served in Sprague-Dawley rats, body weight was equal at the
time of uninephrectomy in both groups, and the magnitude of
weight loss in cyclosporine treated rats (9 4 g) was equal to
the weight loss in controls (17 2). The increase in kidney
weight occurring between the day of uninephrectomy and the
day of micropuncture was equal in control (144.0 19.5 mg)
and cyclosporine treated animals (137.3 46.4 mg). In Munich-
Wistar rats whole blood cyclosporine levels were 3850 154
ig/ml (N = 4), values not different from those in Sprague-
Dawley rats (P> 0.1).
Arterial blood pressure, plasma protein concentration and
hematocrit were not different between cyclosporine and control
rats (Table 1). Whole kidney glomerular filtration rate was
reduced in all cyclosporine treated rats (1.10 .07 vs. 1.55
.13 ml!min, P < 0.01), as were values for single nephron GFR
(31.07 2.27 vs. 42.36 2.47 nl/min, P < 0.005). In cyclo-
sporine treated rats values for whole kidney GFR averaged 74
6% of mean values for GFR in controls, and similarly, mean
SNGFR in cycbosporine rats averaged 74 5% of values for
SNGFR in controls. Glomerular capillary hydrostatic pressure
and intratubule hydrostatic pressure were also the same in both
groups. The lower GFR in cyclosporine treated rats could not
be ascribed to differences in renal perfusion pressure, afferent
arteriolar oncotic pressure or the transglomerular hydrostatic
pressure gradient. Mean values for nephron plasma flow in
cyclosporine treated rats (147.4 13.5 nl!min) were not dif-
ferent from control values (177.0 20.0 nl!min). This is
consistent with the observation in Sprague-Dawley rats where
whole kidney blood flow was the same in cyclosporine and
control groups. Calculated resistances at the afferent and ef-
ferent arteriole were the same in control and cyclosporine
treated rats.
In seven of the eight control rats, the average efferent
arteriolar oncotic pressure was significantly less than the mean
value for the transgbomerular hydrostatic pressure gradient, a
condition characterizing filtration pressure disequilibrium [27,
28]. This was also present in all cyclosporine treated rats, and
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thus, unique values for K1 could be computed in 15 of the 16
animals studied. As shown in Table 1, K1 was significantly
lower in cyclosporine treated rats compared to controls (0.039
0.002 vs. 0.075 0.013 nl/(sec . mm Hg, P <0.025)).
Discussion
Cyclosporine reduced GFR in both Sprague-Dawley and
Munich-Wistar rats and reduced it to similar extent. In the latter
species, both SNGFR and whole kidney GFR fell proportion-
ally, indicating that the impaired glomerular filtration is distrib-
uted equally in nephrons throughout the renal cortex. Thus our
measurements of the forces and flows in the superficial nephron
glomerular circulation would seem to be representative of
glomerular hemodynamics in deeper nephrons which are inac-
cessible to micropuncture.
The low GFR induced by cyclosporine in Sprague-Dawley
rats was not due to differences in arterial blood pressure or
cardiac output, nor was it due to a reduction in renal blood flow,
as this, too, was normal in cyclosporine treated rats. After 14
days of cyclosporine, treated rats lost more body weight than
controls, a difference that could not be accounted for by
differences in food intake, urine output or electrolyte excretion.
Similar to these observations, other investigators have found
that cyclosporine causes weight loss in animals which cannot be
accounted for by differences in food intake or increased urine or
gastrointestinal output [10, 11, 17, 18]. The cause of this effect
is not apparent. The reduced sodium and potassium excretion
and slight but statistically significant increase in serum potas-
sium observed in cyclosporine treated rats have also been noted
by others [11, 12, 29, 301 and may involve direct or indirect
effects of cyclosporine on tubule reabsorption. As arterial blood
pressure, cardiac output and renal blood flow did not differ in
control and cyclosporine treated rats, and there were no docu-
mented losses of fluid and electrolytes during the balance
studies, it is unlikely that extracellular volume depletion could
account for the low glomerular filtration rate in cyclosporine
treated rats.
Micropuncture of the Munich-Wistar rats confirmed the
whole animal data and showed that renal blood flow was not
reduced in cyclosporine treated animals. Similarly, renal perfu-
sion pressure, systemic oncotic pressure, and the transglomer-
ular hydrostatic pressure gradient were not different from
controls. The only abnormality in cyclosporine treated rats was
a reduction in K1, and this was solely responsible for the fall in
GFR.
As K1 is a function of both the permeability of the glomerular
capillary membrane and its surface area available for filtration,
one or both of these parameters may have been reduced by
cyclosporine. An action of cyclosporine on the glomerular
capillary ultrafiltration coefficient has been suggested by other
investigators. Myers et al [8] studied recipients of cardiac
transplants who had received cyclosporine for an average of 12
months. On the basis of fractional clearances of graded-sized
dextrans these investigators determined that while renal blood
flow was reduced, the fall in GFR was more likely explained by
a low glomerular ultrafiltration capacity. More recently, Perico
and associates [13] studied rats who received oral cyclosporine
on alternate days for three months. In treated rats, the GFR was
reduced but renal blood flow was not significantly different than
controls. They too suggested that cyclosporine may lower K1.
This was further supported by their observation that after seven
weeks of cyclosporine, selective inhibition of renal thrombox-
ane A2 synthesis increased GFR without changing renal blood
flow, Finally, Barros ct al [91 have more recently shown that
when administered acutely, cyclosporine lowers K1. The
present study extends these observations by demonstrating an
effect of cyclosporine on Kf following more chronic administra-
tion.
The cause of the reduced Kf was not explored, but several
possibilities may be considered. Cyclosporine may activate the
renin-angiotensin system and increase the local generation of
angiotensin II, [9] a potent constrictor of mesangial cells [31].
Adrenergic tone can be increased following administration of
cyclosporine [7], and this too may reduce K1 [321. Alterations in
renal eicosanoid metabolism has been described in cyclosporine
nephrotoxicity [12, 13, 331 and such alterations may cause
mesangial cell contraction and reduce K1 [34]. Recently, Meyer-
Lehnert and Schrier [351 have shown that cyclosporine aug-
ments hormone sensitive increases in intracellular free calcium
in mesangial cells and augments their contraction. Taken to-
gether the experimental evidence indicates that cyclosporine
reduces K1 by increasing the state of contraction of mesangial
cells under the influence of circulating or locally generated
vasoconstrictors [36, 37]. It is important to note that in the
study of Meyer-Lehnert and Schrier [351 an effect of cyclo-
sporine on mesangial cells harvested from Sprague-Dawley rats
occurred at cyclosporine concentrations of 5 to 10 jig/mI. These
levels are similar to those described in this and another report of
experimental cyclosporine nephrotoxicity [38], but are nearly
an order of magnitude greater than levels seen in clinical
medicine. The nature of the species variability in the suscepti-
bility to cyclosporine is not clear. Finally, an effect of cyclo-
sporine on K1 may be the result of more chronic effects of the
drug on glomerular architecture. Although renal morphology
was not examined in the present study, chronic cyclosporine
nephrotoxicity is characterized by patchy tubulointerstitial in-
filtrate, arteriolopathy and focal glomerular sclerosis [8, 39]. It
is conceivable that an antecedent functional correlate of the
latter is a reduction in K1.
It is interesting that renal blood flow was not reduced in
cyclosporine treated rats, because most [7—Il], but not all
studies [131, point to a prominent role for renal vasoconstriction
in cyclosporine nephrotoxicity. Urinary volume and sodium
excretion were lower in cyclosporine treated rats during the
course of the studies. Therefore, it is conceivable that these rats
were volume expanded even though no differences in plasma
protein concentration, hematocrit, arterial blood pressure and
cardiac output were observed between the two groups. It could
be argued, then, that because renal blood flow was not appro-
priately elevated for the state of hydration, cyclosporine treated
rats had an abnormal renal vascular response to volume expan-
sion. In a previous report abnormal vascular reactivity has been
described in cyclosporine nephrotoxicity [11]. Also, it may be
that the recent uninephrectomized state and the renal hyper-
emia that accompanies it [40] conditions the renal vasculature in
such a way as to modify cyclosporine induced vasoconstriction.
For example, following uninephrectomy renal cortical renin
content is lower than in intact, two-kidney controls [41]. Also,
during renal growth the cross-sectional area of the intrarenal
arterioles is increased [42]. These and other renal responses to
Winston et a!: Renal hemodynamics and cyclosporine 1181
uninephrectomy may have obscured the vasoconstriction com-
monly observed in experimental cyclosporine nephrotoxicity.
We did not directly test whether uninephrectomized rats have a
different susceptibility to cyclosporine nephrotoxicity than do
two-kidney animals, or whether an effect of cyclosporine on
either blood flow or K1 would be dose-related. We do demon-
strate, however, that cyclosporine can reduce GFR without
reducing RBF, that in our model the fall in GFR is not
associated with changes in P0, and that the fall in GFR is due
to a reduction in K1. As there is much experimental evidence to
indicate that cyclosporine has both vascular and glomerular
effects, the particular hemodynamic expression of cyclosporine
nephrotoxicity may be conditioned by the antecedent state of
the glomerular microcirculation.
The increase in kidney weight 7 or 14 days after uninephrec-
tomy in cyclosporine treated rats was equal in magnitude to that
in controls, indicating that while cyclosporine reduced the GFR
it did not interfere with this measure of renal growth. It is
possible that more sensitive morphologic and biochemical mea-
sures of compensatory renal growth [43] were affected by
cyclosporine.
In summary, the present studies demonstrate that the daily
administration of cyclosporine to rats following uninephrec-
tomy causes renal insufficiency. While the GFR is reduced, the
expected increase in renal mass is not affected by cyclosporine.
In this model of chronic cyclosporine nephrotoxicity, the fall in
GFR does not depend on a reduced renal blood flow or changes
in P, but depends on a reduction in the glomerular capillary
ultrafiltration coefficient. The mediators of this response remain
to be determined, but cyclosporine can have direct effects on
mesangial cell function.
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